Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Paratek Pharma Inc
(NQ:
PRTK
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 20, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
2.180 (505)
Ask (Size)
2.250 (20)
Prev. Close
2.230
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
52,366,173
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Leading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings
September 07, 2023
From
Paratek Pharmaceuticals, Inc.
Via
GlobeNewswire
Investor Alert: Abbott Cooper PLLC Announces Investigation into Paratek Pharmaceuticals, Inc.; Urges Paratek Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
August 09, 2023
From
Abbott Cooper PLLC
Via
Business Wire
Performance
More News
Read More
PRTK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Paratek Pharmaceuticals, Inc. Is Fair to Shareholders
June 11, 2023
From
Halper Sadeh LLC
Via
Business Wire
Paratek Pharmaceuticals Agrees To Be Taken Private By Gurnet Point And Novo Holdings For $462M
June 06, 2023
Via
Benzinga
Recap: Paratek Pharmaceuticals Q1 Earnings
May 09, 2023
Via
Benzinga
Paratek Pharmaceuticals Earnings Perspective: Return On Capital Employed
March 17, 2023
Via
Benzinga
Why Paratek Pharmaceuticals Stock Is Plunging Today
March 16, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
June 07, 2023
Via
Benzinga
Why Paratek Pharmaceuticals Stock Is Up Today
June 06, 2023
Via
Benzinga
7 Growth Stocks That Are Too Cheap to Ignore Right Now
May 10, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
April 24, 2023
Via
Benzinga
Paratek Pharmaceuticals Earnings Preview
March 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 31, 2023
Via
Benzinga
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 31, 2023
Via
Benzinga
$1.6M Bet On ATAI Life Sciences? Check Out These 4 Penny Stocks Insiders Are Buying
March 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 16, 2023
Via
Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 14, 2023
Via
Benzinga
Earnings Preview For Paratek Pharmaceuticals
August 02, 2022
Via
Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Via
Benzinga
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
June 22, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.